fda warning letters glp-1 compounding september 26 2025 Why the Issued 30 to Telehealth Sites Marketing Compounded GLP-1s FDA Drug Recalls and Warnings:
Description
While these medications can help regulate appetite and support weight loss, sustainable success comes from pairing them with smart, supportive choices

Purpose of Review This review explores the role of GLP-1 receptor agonists (GLP-1 RAs) in addressing metabolic dysfunction and neurodegeneration in Parkinsons disease (PD), focusing on body weight regulation and neuroprotection

Several randomized controlled trials have demonstrated the benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on ischemic stroke in patients with diabetes

CNBC's Bertha Coombs joins 'Squawk on the Street' to report on Biden's administration plan to expand coverage of GLP-1 drugs for Americans with Medicare and Medicaid.

Further research is warranted to elucidate underlying mechanisms and optimize patient selection.